- Home
- / NeRRe Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
NeRRe Therapeutics financials data including stock price, CreditSafe score, and balance sheet.
Total Funding
$49.2 M
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|
| Cash | 1.4M | 1.9M | 2.7M | 4.0M | 8.0M |
| Accounts Receivable | 322.7K | ||||
| Current Assets | 1.7M | 2.2M | 3.0M | 5.7M | 10.3M |
| PP&E | 3.2K | 2.6K | 4.3K | 16.5K | 11.6K |
| Total Assets | 2.6M | 3.0M | 3.7M | 6.3M | 10.7M |
| Accounts Payable | 589.4K | 222.7K | 227.8K | 1.2M | 1.3M |
| Current Liabilities | 589.4K | 1.1M | 430.2K | 1.7M | 2.0M |
| Long-term Debt | 1.7M | 1.5M | 3.3M | ||
| Non-Current Liabilities | 1.3M | 1.7M | 1.5M | 3.3M | |
| Total Debt | 1.7M | 1.5M | 3.3M | ||
| Total Liabilities | 1.9M | 2.8M | 1.9M | 5.0M | 2.0M |
| Common Stock | 35.0 | 35.0 | 634.0 | 1.7K | 2.7K |
| Retained Earnings | (2.6M) | (4.3M) | (5.4M) | (12.3M) | (18.8M) |
| Total Equity | 730.9K | 156.0K | 1.8M | 1.2M | 8.7M |
| Financial Leverage | 3.5 | 19.1 | 2.1 | 5.1 | 1.2 |